Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (11-20 of 325) with videos related to

Pageof 33
Sort By:
Leukemia & Lymphoma|June 9, 2011
Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approachClive S Zent, Neil E Kay
Lancet (London, England)|July 31, 2007
Combination therapies for previously untreated CLLTait D Shanafelt, Neil E Kay
Best Practice & Research. Clinical Haematology|July 13, 2010
Autoimmune complications in chronic lymphocytic leukaemia (CLL)Clive S Zent, Neil E Kay
Advances in Experimental Medicine and Biology|September 10, 2013
Critical signal transduction pathways in CLLAsish K Ghosh, Neil E Kay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2017
Reply to S. Opat et alJennifer R Brown, Neil E Kay
Leukemia & Lymphoma|July 12, 2003
IL-4 biology: impact on normal and leukemic CLL B cellsNeil E Kay, Brian T Pittner
Current Oncology Reports|August 5, 2004
Advances in the understanding of biology and prognosis in chronic lymphocytic leukemiaClive S Zent, Neil E Kay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2017
Chemoimmunotherapy Is Not Dead Yet in Chronic Lymphocytic LeukemiaJennifer R Brown, Neil E Kay
Blood|August 1, 2002
B-CLL: is the enigma of disease heterogeneity about to be revealed?Neil E Kay, Diane F Jelinek
Current Hematologic Malignancy Reports|April 29, 2010
Prognostic factors in chronic lymphocytic leukemiaNeil E Kay, Tait D Shanafelt
Pageof 33

Showing results (11-20 of 325) with videos related to

Sort By:
Pageof 33
Leukemia & Lymphoma|June 9, 2011
Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approachClive S Zent, Neil E Kay
Lancet (London, England)|July 31, 2007
Combination therapies for previously untreated CLLTait D Shanafelt, Neil E Kay
Best Practice & Research. Clinical Haematology|July 13, 2010
Autoimmune complications in chronic lymphocytic leukaemia (CLL)Clive S Zent, Neil E Kay
Advances in Experimental Medicine and Biology|September 10, 2013
Critical signal transduction pathways in CLLAsish K Ghosh, Neil E Kay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2017
Reply to S. Opat et alJennifer R Brown, Neil E Kay
Leukemia & Lymphoma|July 12, 2003
IL-4 biology: impact on normal and leukemic CLL B cellsNeil E Kay, Brian T Pittner
Current Oncology Reports|August 5, 2004
Advances in the understanding of biology and prognosis in chronic lymphocytic leukemiaClive S Zent, Neil E Kay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2017
Chemoimmunotherapy Is Not Dead Yet in Chronic Lymphocytic LeukemiaJennifer R Brown, Neil E Kay
Blood|August 1, 2002
B-CLL: is the enigma of disease heterogeneity about to be revealed?Neil E Kay, Diane F Jelinek
Current Hematologic Malignancy Reports|April 29, 2010
Prognostic factors in chronic lymphocytic leukemiaNeil E Kay, Tait D Shanafelt
Pageof 33